Supplied for research purposes only. These peptides are laboratory reagents intended for qualified researchers and educational institutions. Not for human use, animal use, or clinical application.
The Wolverine Stack Research Blend is a dual-peptide kit comprising BPC-157 and TB-500 (Thymosin β4 fragment) — engineered to support integrated investigations into cryoprotection, cell migration, and musculoskeletal repair pathways. Designed for researchers studying synergistic effects on wound healing, tendon regeneration, and inflammatory modulation, this stack enables controlled co-administration studies. All components are supplied as individual lyophilised solids — not pre-mixed — to ensure stability, traceability, and full regulatory compliance.
Supplied as two separate lyophilised vials (BPC-157 + TB-500) — never pre-formulated — for research integrity and MHRA alignment.
What is the Wolverine Stack Research Blend?
The Wolverine Stack is a RUO research kit comprising:
TB-500 (CAS 62568-57-4): 43-amino-acid fragment of Thymosin β4 for G-actin sequestration and cell motility
Each peptide is independently synthesised, QC-tested, and supplied with full CoA. The stack is not a drug, formulation, or supplement — but a research tool for combinatorial pathway analysis in tissue resilience models [Šebečić et al., J Physiol Pharmacol 1996; Bock et al., J Biol Chem 1989]. Supplied exclusively for in vitro, ex vivo, and preclinical research — not for human or veterinary use.
🔬 Note: “Wolverine Stack” is a community-derived protocol nickname. NovaVitality makes no claims of enhanced regeneration. All use must comply with institutional biosafety and ethics requirements.
2× lyophilised solids (white to off-white powder) in amber vials
Purity
≥98% each (HPLC-UV), endotoxin <0.5 EU/mg
Storage
Store both vials at −20°C, protected from light and moisture
Unit Sizes
2×10 mg, 2×20 mg
Usage and Reconstitution
Each peptide is reconstituted separately, per validated protocol: ✅ BPC-157: sterile 0.9% NaCl (highly soluble, no warming needed) ✅ TB-500: bacteriostatic water or 0.1% acetic acid in saline (gentle sonication may aid dissolution)
⚠️ Critical Handling Notes: – Do not pre-mix — differing optimal pH (BPC-157: neutral; TB-500: mildly acidic) risks precipitation. – Administer sequentially (e.g., BPC-157 first for vascular priming, TB-500 after for migration) or in parallel per protocol. – Filter each through 0.22 µm PVDF for in vivo or cell work.
📚 Protocol-first design: Science-led — no “miracle” claims, full support for mechanistic studies
🛡️ RUO integrity: Meets MHRA GMP Guide, FDA 21 CFR 1271, EU Annex 1
💬 Stack optimisation support: Get help with temporal sequencing, dose ratios (e.g., 1:1 vs 2:1 BPC:TB-500), or in vivo delivery routes
Legal and Safety Information
NovaVitality supplies the Wolverine Stack Research Blend strictly for laboratory research, assay development, and educational purposes (RUO).
❌ This product is not approved by the MHRA, FDA, EMA, or any regulatory authority for: → Human use → Veterinary use → Diagnostic, therapeutic, or cosmetic use
⚠️ Critical Responsibilities for Researchers: – Use only under approved institutional biosafety protocols – Comply with local ethics oversight (e.g., AWERB, IACUC) – Do not pre-mix peptides without stability validation – Maintain full chain-of-custody for both components – “Wolverine Stack” is a research-protocol nickname — not a branded product or efficacy claim
🔒 NovaVitality disclaims all liability for misuse. By purchasing, you affirm compliance with all applicable laws and institutional policies.
Ready to Advance Dual-Peptide Tissue Repair Research?
![Melanotan 2 (Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH₂) research peptide: cyclic MC1R/MC4R superagonist for melanocortin receptor bias and energy homeostasis studies — RUO, UK MHRA-compliant research supply.](https://novavitality.co.uk/wp-content/uploads/2025/12/xCard-6-500x482.png.pagespeed.ic.hQELyHQV1s.png "Melanotan 2 Research Peptide — Cyclic Melanocortin Receptor Super agonist (RUO)")
